Spots Global Cancer Trial Database for the first line chemotherapy for metastatic nsclc
Every month we try and update this database with for the first line chemotherapy for metastatic nsclc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC) | NCT04255836 | Carcinoma, Non-... | Durvalumab the first line ... stereotactic bo... | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC) | NCT04255836 | Carcinoma, Non-... | Durvalumab the first line ... stereotactic bo... | 18 Years - 80 Years | Zhejiang Cancer Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
